Perigon Wealth Management LLC Makes New $829,000 Investment in MetLife, Inc. $MET

Perigon Wealth Management LLC purchased a new position in MetLife, Inc. (NYSE:MET) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 9,796 shares of the financial services provider’s stock, valued at approximately $829,000.

Other hedge funds also recently made changes to their positions in the company. Strs Ohio lifted its stake in MetLife by 16.6% in the 4th quarter. Strs Ohio now owns 326,091 shares of the financial services provider’s stock worth $25,742,000 after purchasing an additional 46,469 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of MetLife by 2.1% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 714,193 shares of the financial services provider’s stock valued at $56,712,000 after purchasing an additional 14,515 shares in the last quarter. PFA Pension Forsikringsaktieselskab bought a new position in shares of MetLife in the fourth quarter worth $81,494,000. Evergreen Capital Management LLC raised its position in shares of MetLife by 195.8% in the fourth quarter. Evergreen Capital Management LLC now owns 33,260 shares of the financial services provider’s stock worth $2,626,000 after buying an additional 22,016 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its stake in MetLife by 2.2% during the fourth quarter. Principal Financial Group Inc. now owns 622,789 shares of the financial services provider’s stock valued at $49,163,000 after buying an additional 13,657 shares during the period. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MET has been the topic of a number of research analyst reports. Wall Street Zen lowered MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Jefferies Financial Group lifted their price target on MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a research report on Friday, July 10th. UBS Group boosted their price objective on MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. Barclays upped their price objective on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.07.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Trading Up 0.2%

Shares of MET stock opened at $96.83 on Wednesday. The business has a 50-day moving average price of $92.00 and a two-hundred day moving average price of $81.86. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $100.93. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm has a market cap of $62.31 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $2.30 by $0.13. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The company’s revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the company earned $2.02 EPS. Equities analysts anticipate that MetLife, Inc. will post 9.7 EPS for the current fiscal year.

MetLife announced that its Board of Directors has initiated a share buyback plan on Wednesday, August 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s dividend payout ratio (DPR) is presently 45.40%.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.